Why founders often walk into acquisitions unprepared—and what it can cost them.
Selling a startup is often cast as the grand finale—the long-awaited reward for the years spent bootstrapping, pitching, surviving cash crunches, and building a company from scratch. But for many founders, what’s billed as a victory lap turns into a slog of asymmetries, power imbalances, and, too often, heartbreak.
“I’m selling my startup” sounds like a triumphant headline. In reality, it’s the beginning of one of the most complex and emotionally draining chapters in a founder’s journey.
Over the past two to three years, the ag-tech sector has been relatively quiet. The last wave of significant capital raises—featuring names like Indigo, FBN, and Bushel—feels increasingly distant. While niche areas of the industry remain active, founders looking to exit today find themselves operating in a much different environment, where strategic buyers hold more leverage than ever before.
In my work advising early-stage companies, I’ve seen founders walk into the sales process with optimism—and walk away wounded. Some never recover.
The First Mistake: Not Seeing the Asymmetry
Selling a company is rarely a fair fight.
Buyers are typically established, well-capitalized enterprises. They bring in dedicated corporate development teams, backed by budgets and institutional support, to evaluate and execute acquisitions. These teams are focused, analytical, and risk-averse. Their job is to protect the company—dotting every “i,” scrutinizing every spreadsheet, and controlling the narrative.
Founders, on the other hand, are often stretched thin even before the sale begins. Many are juggling payroll, product development, marketing, and fundraising—just keeping the lights on. When a prospective buyer enters the picture, founders must suddenly shift their attention to data rooms, due diligence, and long negotiation cycles. There’s no dedicated M&A team. Just them.
The result? Momentum slows. Core operations suffer. And the very things that made the startup attractive in the first place—its agility, vision, and growth trajectory—begin to stall.
Mismatched Timelines, Misaligned Goals
The acquiring company may be driven by a long-term strategic vision—one endorsed by a senior executive eager to bolster their portfolio or head off a looming threat. But the due diligence is often delegated to a business development or M&A team that doesn’t share the same urgency or vision. Their focus is on risk mitigation, not innovation. They’re not in the field. They’re in spreadsheets.
Meanwhile, the founder is racing against a runway that’s shrinking by the day. Cash reserves, once earmarked for product enhancements or market expansion, are diverted to serve the sale process. Weeks turn into months. Four to eight months is a typical timeline. Often longer.
And then? The buyer might walk. Or delay. Or request “just a bit more analysis.”
By then, the startup’s trajectory has been interrupted. Its capital may be depleted. The founder, exhausted. The company, in some cases, irreparably damaged.
The Hard Truth Most Founders Miss
Founders tend to underestimate the toll of the acquisition process. They overestimate the clarity of the buyer’s intentions. And they rarely prepare for the structural imbalance at the heart of the deal.
The truth is: buyers have teams, time, and capital. Sellers have urgency, emotional investment, and often, blind hope.
Too often, I’m called in after the deal falls apart. The capital’s gone. The team is demoralized. And the dream that once seemed so close is suddenly on life support.
The better time to call? Before the process begins. When the startup still has leverage. When the founder still has choices.
Selling a startup isn’t just a financial transaction. It’s an emotional pivot, a shift from building to letting go. For founders, the best outcomes often come not from rushing toward the finish line—but from understanding the terrain before the race even begins.
